CONGENITAL PARVOVIRUS B19 INFECTION

This adverse event was reported 1 times

These drugs are most commonly taken by patients reporting CONGENITAL PARVOVIRUS B19 INFECTION:

# Drug Count
0 ASPIRIN 1
1 ASPIRIN 325 MG 1
2 ASPIRIN 81 MG 1
3 CALCIUM 1
4 TALIGLUCERASE ALFA 1
See all common drugs associated with CONGENITAL PARVOVIRUS B19 INFECTION

CONGENITAL PARVOVIRUS B19 INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TALIGLUCERASE ALFA 1 0.0017
1 ASPIRIN 1 0.0000
See all drugs enriched for association with CONGENITAL PARVOVIRUS B19 INFECTION

CONGENITAL PARVOVIRUS B19 INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
1 Calcium [EPC] 1 0.0000
2 Platelet Aggregation Inhibitor [EPC] 1 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with CONGENITAL PARVOVIRUS B19 INFECTION